We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




Ingested Dual Balloon Encourages Weight Loss

By HospiMedica International staff writers
Posted on 12 Aug 2015
Print article
Image: The ReShape Integrated Dual Balloon System (Photo courtesy of ReShape Medical).
Image: The ReShape Integrated Dual Balloon System (Photo courtesy of ReShape Medical).
A novel non-surgical weight loss procedure aids people who either do not want or do not qualify for bariatric surgery.

The ReShape Integrated Dual Balloon System consists of two connected balloons that occupy space in the stomach, so that patients feel satiety with smaller portions of food. The system is inserted via an endoscopic procedure; once in place, the two balloons are inflated using saline, and remain in the stomach for six months to help reduce hunger. During these first six months, and for the six months after the balloons are removed, patients receive comprehensive counseling and support services that include frequent in-office coaching sessions.

The ReShape provides a personalized pathway broken down into three phases over the 12 months. The first phase involves a personalized evaluation and education session. The two balloons are then inserted in the stomach in a 20 minute procedure. This is followed by personalized coaching, with a focus on healthy eating, exercise, and lifestyle habits, to maximize treatment success. The balloons are removed at six months, with six monthly sessions continuing onwards thereafter to set goals and track progress.

To help patients monitor their progress, a ReShape Patient Portal provides weight logging, food logging, activity tracking, goal setting, articles and recipes, community forums, and other important reminders. The portal can be accessed from a smartphone or tablet, and the Fitbit (San Francisco, CA, USA) wireless scale and activity tracker can be integrated as well to integrate all weight loss data in one place.

The ReShape Integrated Dual Balloon System is a product of ReShape Medical (San Clemente, CA, USA), and has been approved by the US Food and Drug Administration (FDA). It is indicated for weight reduction when used in conjunction with diet and exercise, in obese patients with a body mass index (BMI) of 30–40 kg/m2, one or more obesity-related comorbidity conditions, and who have failed weight reduction with diet and exercise alone.

“Many Americans have struggled with a lack of effective weight loss options when their BMI is in the 30–40 range,” said John Morton, MD, MPH, president of the American Society for Metabolic and Bariatric Surgery (Gainesville, FL, USA). “Options like ReShape address a significant gap that exists between diet and exercise, weight loss medications and surgery, offering a minimally invasive, reversible option which we hope will promote long-term healthy habits.”

Related Links:

ReShape Medical
Fitbit
American Society for Metabolic and Bariatric Surgery


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Gold Member
X-Ray QA Meter
T3 AD Pro
New
In-Bed Scale
IBFL500
New
Hospital Data Analytics Software
OR Companion

Print article

Channels

Critical Care

view channel
Image: Changes in immune cells can predict patient recovery following out-of-hospital cardiac arrest (Photo courtesy of Adobe Stock)

Activating T Cells Could Improve Neurological Outcomes After Cardiac Arrest

Despite advancements in cardiopulmonary resuscitation (CPR) and improved hospital access, survival rates after out-of-hospital cardiac arrest (OHCA) remain low, with only about 10% of patients surviving.... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The acoustic pipette uses sound waves to test for biomarkers in blood (Photo courtesy of Patrick Campbell/CU Boulder)

Handheld, Sound-Based Diagnostic System Delivers Bedside Blood Test Results in An Hour

Patients who go to a doctor for a blood test often have to contend with a needle and syringe, followed by a long wait—sometimes hours or even days—for lab results. Scientists have been working hard to... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.